Suppr超能文献

血浆中载脂蛋白A-I多态性的起源。

Origin of apolipoprotein A-I polymorphism in plasma.

作者信息

Ghiselli G, Rohde M F, Tanenbaum S, Krishnan S, Gotto A M

出版信息

J Biol Chem. 1985 Dec 15;260(29):15662-8.

PMID:4066689
Abstract

The origin and the functional significance of apo-A-I polymorphism in man has been investigated. Together with proapo-A-I (identified as A-I1 of the polymorphic series), four other isoforms are found in human plasma, namely A-I2, A-I3, A-I4, and A-I5. A-I3 is the "mature" product of proapo-A-I conversion in plasma. In this study we provide evidence that the other, more acidic, mature apo-A-I isoproteins are derived from A-I3 by a stepwise deamidation process. This conclusion is based on the following observations. 1) Incubation of A-I3 or A-I4, either free or associated with high density lipoprotein, produces a series of more acidic isoproteins corresponding to the sequence found in plasma. The conversion process fits in well with a first order reaction, and A-I3 to A-I4 conversion occurs virtually at the same rate as A-I4 to A-I5 conversion. 2) A-I3 and A-I4 have the same NH2- and C-terminal residues. 3) Formation of apo-A-I acidic isoproteins is accompanied by liberation of ammonia. In order to investigate whether deamidation of apo-A-I results in the production of forms which have different catabolism, a series of turnover studies was carried out in normal volunteers. A-I3 and A-I4 residence times in plasma were, respectively, 3.50 +/- 0.16 and 3.00 +/- 0.10 days (mean +/- S.E.; n = 3). Degradation rate of A-I3 was 8.81 +/- 0.69 mg/kg/day and that of A-I4 was 1.66 +/- 0.15 mg/kg/day (mean +/- S.E.; n = 3). Conversion of A-I3 to A-I4 and A-I4 to A-I5 occurred at the same rate in vivo as that observed in vitro. These results are consistent with the concept that A-I3 is the precursor to the other mature apo-A-I isoforms in plasma. A-I3 is the major isoform through which apo-A-I is eliminated from plasma.

摘要

对人类载脂蛋白A-I多态性的起源及其功能意义进行了研究。除了前载脂蛋白A-I(被确定为多态性系列中的A-I1)外,在人血浆中还发现了其他四种异构体,即A-I2、A-I3、A-I4和A-I5。A-I3是血浆中前载脂蛋白A-I转化的“成熟”产物。在本研究中,我们提供证据表明,其他酸性更强的成熟载脂蛋白A-I同工蛋白是通过逐步脱酰胺过程从A-I3衍生而来的。这一结论基于以下观察结果。1) 游离或与高密度脂蛋白结合的A-I3或A-I4孵育会产生一系列酸性更强的同工蛋白,与血浆中发现的序列相对应。转化过程符合一级反应,A-I3向A-I4的转化速率与A-I4向A-I5的转化速率几乎相同。2) A-I3和A-I4具有相同的氨基末端和羧基末端残基。3) 载脂蛋白A-I酸性同工蛋白的形成伴随着氨的释放。为了研究载脂蛋白A-I的脱酰胺是否会导致产生具有不同分解代谢的形式,在正常志愿者中进行了一系列周转率研究。A-I3和A-I4在血浆中的停留时间分别为3.50±0.16天和3.00±0.10天(平均值±标准误;n = 3)。A-I3的降解速率为8.81±0.69 mg/kg/天,A-I4的降解速率为1.66±0.15 mg/kg/天(平均值±标准误;n = 3)。A-I3向A-I4和A-I4向A-I5的转化在体内的发生速率与体外观察到的速率相同。这些结果与A-I3是血浆中其他成熟载脂蛋白A-I同工型的前体这一概念一致。A-I3是载脂蛋白A-I从血浆中清除的主要同工型。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验